NASDAQ · MMSI
Merit Medical Systems, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for MMSI has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $1.01 | $1.03 | $0.98 | 5 |
| Mar 2027 | $0.89 | $0.92 | $0.86 | 4 |
| Jun 2027 | $1.07 | $1.14 | $1.02 | 4 |
| Sep 2027 | $1.04 | $1.07 | $1.01 | 4 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · Zacks · RTTNews- Fintel · Oct 29, 11:41 PM EDTMerit Medical Systems, Inc. Acquires Solo Pace for Approximately $45 Million and Reports Third Quarter 2026 ResultsMerit Medical Systems, Inc. announced that on October 13, 2026, it paid purchase consideration of approximately $45 million to acquire all remaining outstanding equity of Solo Pace, Inc. Merit previously owned approximately 18% of Solo Pace pursuant to various agreements executed
- Zacks · Oct 29, 6:05 PM EDTMerit Medical (MMSI) Q3 Earnings and Revenues Beat EstimatesMerit Medical (MMSI) delivered earnings and revenue surprises of +7.69% and +1.43%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Oct 29, 5:30 PM EDTMerit Medical (MMSI) Reports Q3 Earnings: What Key Metrics Have to SayAlthough the revenue and EPS for Merit Medical (MMSI) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- RTTNews · Oct 29, 5:02 PM EDTMerit Medical Systems Inc Reveals Increase In Q3 Profit(RTTNews) – Merit Medical Systems Inc (MMSI) reported a profit for its third quarter that Increases, from the same period last year
- Zacks · Oct 29, 12:24 PM EDTReasons to Hold Hinge Health Stock in Your Portfolio for NowHNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.
- Zacks · Oct 27, 1:30 PM EDTEcolab Q3 Earnings In-Line With Estimates, Revenues Increase Y/YECL's Q3 earnings increase 5% to $2.18 per share, while revenues jump 13%, driven by strong Water and Life Sciences growth and accelerating digital sales.
- Zacks · Oct 27, 1:29 PM EDTHere's Why You Should Hold PacBio Stock in Your Portfolio for NowPACB's growing clinical adoption, advanced sequencing technologies and rising consumables sales support growth, but funding headwinds and margin pressures persist.
- Zacks · Oct 23, 11:19 AM EDTSOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.TherapySolventum gains FDA clearance to combine Restrata Matrix with V.A.C. Therapy, potentially expanding wound care applications and supporting long-term growth.
- Zacks · Oct 22, 9:42 AM EDTGEHC Expands Theranostics Imaging With 5 Global CollaborationsGE HealthCare expands its theranostics imaging push with five global collaborations to evaluate StarGuide GX, targeting advances in precision oncology and nuclear medicine.
- Zacks · Oct 21, 7:14 AM EDTStryker's Sonopet 3 Secures FDA Clearance to Improve Surgical AccuracySYK's Sonopet 3 secures FDA clearance, promising enhanced surgical precision and efficiency, with a full commercial launch expected later this fall.
- Zacks · Oct 16, 10:20 AM EDTOPKO Health to Sell Select BioReference Assets to Labcorp for $722MOPK's $722M BioReference asset sale to Labcorp, with a potential $150M earnout, aims to sharpen its biopharma focus and expand access to the 4Kscore Test.
- Zacks · Oct 15, 12:22 PM EDTBD's Revello Stent Shows Strong AGILITY Trial Results for PAD PatientsBDX's Revello stent shows strong nine-month AGILITY trial results, with high vessel patency and low failure rates, boosting its peripheral vascular prospects.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Merit Medical Systems, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.